Emerging evidence indicates that mitochondrial dysfunction represents a central pathogenic feature of PD, integrating the impact of genetic mutations such as PINK1, PRKN, and LRRK2 and environmental exposure to neurotoxins such as Rotenone and MPTP. The gene discussed is PRKN; the disease is Parkinson disease.